Capital Group Core Equity ETF

CGUS

시가총액 US$120억

Capital Group Core Equity ETF (CGUS) is rated Buy for its adaptive active management, outperforming SPY by 1.4% YTD and delivering strong risk-adjusted returns. CGUS's flexible multi-manager approach enables dynamic sector allocation, currently overweighting technology (37.6%) and industrials, supporting its outperformance amid the AI-driven market. With a concentrated portfolio (~70 holdings), CGUS leverages conviction in leaders like Broadcom and Eli Lilly, balancing tech with high-growth healthcare exposure.

Capital Group Core Equity ETF is managed actively, favoring companies with "the potential for capital appreciation and/or dividend payments." Despite underperformance versus the S&P 500 index since my August 2025 article, CGUS maintains a robust long-term track record, with alpha delivered since its inception in February 2022. The CGUS portfolio features 65 equities, with the factor mix being notable for a slight GARP tilt secured by its exposure to the IT and communication sectors.

In a span of just four years, The Capital Group Companies went from ETF rookie to perennial All-Star. The Los Angeles-based firm has already amassed over $120 billion in assets dispersed across its suite of 25 active ETFs.

The Capital Group Core Equity ETF offers a high-conviction, mega-cap-tilted, actively managed portfolio with a balanced sector allocation. CGUS trades at a modest P/E premium (23.2x) to the Russell 1000, largely justified by superior historical earnings growth (13.6%) and profitability metrics. The fund demonstrates strong risk-adjusted returns, outperforming peers in Sharpe ratio (1.46), with lower downside capture and volatility versus the Russell 1000.

CGUS is The Capital Group's Core U.S. Equity ETF with a 0.33% expense ratio and $8.3B in assets under management. It launched nearly four years ago on February 22, 2022. Although not terribly different than SPY from a fundamentals perspective, CGUS could provide slight long-term outperformance by dampening volatility in market downturns. So far, so good. My returns distribution analysis highlights how, despite a lower median monthly return, CGUS has still outperformed SPY by an annualized 0.36% with less volatility.

Capital Group Core Equity ETF offers a balanced growth and income strategy, appealing to moderate-risk investors seeking to outperform the market. CGUS has outperformed the S&P 500 since its 2022 launch, with strong returns in both bull and bear markets, and a quant buy rating of 3.83. The ETF's diversified portfolio features mega-cap tech, industrials, financials, and healthcare stocks, supporting both upside potential and risk mitigation.

CGUS is an actively managed U.S. equities-focused vehicle bringing together growth and income. CGUS has outperformed the S&P 500 index since my September 2024 article. Its returns since inception in 2022 are also confidently higher than IVV's. With the portfolio downsized since September 2024, CGUS has become growthier, which secures its edge over IVV. There are minor issues on the quality front though.

The Capital Group Core Equity ETF (CGUS) has outperformed the Russell 1000 index since its inception in early 2022, despite challenging market conditions. CGUS focuses on long-term capital appreciation and income, with a heavy allocation to mega caps, particularly in technology and communication services sectors. The fund's valuation is in line with the Russell 1000 index, with a P/E ratio of 21.8x, and it boasts higher growth and profitability figures.

With a portfolio of U.S. and international equities, CGUS is supposed to amalgamate growth and income. After assessing the ETF for the second time, I reiterate the Buy rating owing to its impressive performance track record and a mostly robust factor mix (value, growth, and quality). The risk is the broader market correction impacting CGUS as well, but its historical downside capture ratio suggests it should do better than IVV.

Capital Group first launched ETFs less than two and a half years ago, but is not slowing down. The firm's asset base is just under $35 billion, aided by nearly $10 billion thus far in 2024.